BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29524134)

  • 1. CRISPR/dCas9 Switch Systems for Temporal Transcriptional Control.
    Gjaltema RAF; Schulz EG
    Methods Mol Biol; 2018; 1767():167-185. PubMed ID: 29524134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible CRISPR-dCas9 Transcriptional Systems for Sensing and Genome Regulation.
    Wu H; Wang F; Jiang JH
    Chembiochem; 2021 Jun; 22(11):1894-1900. PubMed ID: 33433941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation by CRISPR/dCas9 in common wheat.
    Zhou H; Xu L; Li F; Li Y
    Gene; 2022 Jan; 807():145919. PubMed ID: 34454034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
    Goubert D; Koncz M; Kiss A; Rots MG
    Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
    Lau CH; Suh Y
    Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
    Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
    J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplexed Transcriptional Activation or Repression in Plants Using CRISPR-dCas9-Based Systems.
    Lowder LG; Paul JW; Qi Y
    Methods Mol Biol; 2017; 1629():167-184. PubMed ID: 28623586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/dCas9 platforms in plants: strategies and applications beyond genome editing.
    Moradpour M; Abdulah SNA
    Plant Biotechnol J; 2020 Jan; 18(1):32-44. PubMed ID: 31392820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing CRISPR-Cas9 for Epigenetic Engineering.
    Guerra-Resendez RS; Hilton IB
    Methods Mol Biol; 2022; 2518():237-251. PubMed ID: 35666449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using an Inducible CRISPR-dCas9-KRAB Effector System to Dissect Transcriptional Regulation in Human Embryonic Stem Cells.
    Parsi KM; Hennessy E; Kearns N; Maehr R
    Methods Mol Biol; 2017; 1507():221-233. PubMed ID: 27832543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects.
    Rahman MM; Tollefsbol TO
    Methods; 2021 Mar; 187():77-91. PubMed ID: 32315755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional Regulation with CRISPR/Cas9 Effectors in Mammalian Cells.
    Pham H; Kearns NA; Maehr R
    Methods Mol Biol; 2016; 1358():43-57. PubMed ID: 26463376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-based epigenome editing: mechanisms and applications.
    Fadul SM; Arshad A; Mehmood R
    Epigenomics; 2023 Nov; 15(21):1137-1155. PubMed ID: 37990877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
    Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
    Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice for in vivo epigenome editing with CRISPR-based systems.
    Gemberling MP; Siklenka K; Rodriguez E; Tonn-Eisinger KR; Barrera A; Liu F; Kantor A; Li L; Cigliola V; Hazlett MF; Williams CA; Bartelt LC; Madigan VJ; Bodle JC; Daniels H; Rouse DC; Hilton IB; Asokan A; Ciofani M; Poss KD; Reddy TE; West AE; Gersbach CA
    Nat Methods; 2021 Aug; 18(8):965-974. PubMed ID: 34341582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart.
    Schoger E; Carroll KJ; Iyer LM; McAnally JR; Tan W; Liu N; Noack C; Shomroni O; Salinas G; Groß J; Herzog N; Doroudgar S; Bassel-Duby R; Zimmermann WH; Zelarayán LC
    Circ Res; 2020 Jan; 126(1):6-24. PubMed ID: 31730408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/dCas9-mediated transcriptional improvement of the biosynthetic gene cluster for the epothilone production in Myxococcus xanthus.
    Peng R; Wang Y; Feng WW; Yue XJ; Chen JH; Hu XZ; Li ZF; Sheng DH; Zhang YM; Li YZ
    Microb Cell Fact; 2018 Jan; 17(1):15. PubMed ID: 29378572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing CRISPR System for Transcriptional Activation.
    Chen M; Qi LS
    Adv Exp Med Biol; 2017; 983():147-157. PubMed ID: 28639197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.